Compare Stocks → The attacks will come for me after releasing this… (From Porter & Company) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDigital Media StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare ShareLink copied to clipboard. NASDAQ:CHFSNASDAQ:EYESNASDAQ:NDRAOTCMKTS:PEYE Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHFSNuwellis$0.20$4.79$4.86▼$37.50$1.18M1.55467,323 shs310,604 shsEYESSecond Sight Medical Products$5.67$3.42▼$12.72$54.38M2.55132,982 shs36,800 shsNDRAENDRA Life Sciences$0.10$0.26$0.07▼$2.79$1.14M1.0636.34 million shs53.97 million shsPEYEPrecision Optics$1.95$1.61▼$2.69$32.98M0.419,793 shs113,500 shs7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHFSNuwellis-5.49%-10.41%-14.06%-51.64%-93.51%EYESSecond Sight Medical Products0.00%0.00%0.00%0.00%0.00%NDRAENDRA Life Sciences+2.57%+2.57%-64.34%-89.64%-92.95%PEYEPrecision Optics0.00%0.00%0.00%0.00%0.00%The attacks will come for me after releasing this… (Ad)America’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that, if successful, could be more financially and culturally devastating than the dot-com blowup of 2000, the 2008 financial crisis, or the COVID crash.Click here to see how you can protect yourself today. MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCHFSNuwellisN/AN/AN/AN/AN/AN/AN/AN/AEYESSecond Sight Medical ProductsN/AN/AN/AN/AN/AN/AN/AN/ANDRAENDRA Life Sciences1.4342 of 5 stars3.53.00.00.02.20.00.6PEYEPrecision OpticsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHFSNuwellisN/AN/AN/AN/AEYESSecond Sight Medical ProductsN/AN/AN/AN/ANDRAENDRA Life Sciences3.00Buy$8.007,622.01% UpsidePEYEPrecision OpticsN/AN/AN/AN/ACurrent Analyst RatingsLatest EYES, NDRA, CHFS, and PEYE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/7/2024NDRAENDRA Life SciencesAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$10.00 ➝ $8.00(Data available from 6/15/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHFSNuwellis$5.51M0.21N/AN/A$12.79 per share0.02EYESSecond Sight Medical Products$3.38M0.00N/AN/A$4.80 per share0.00NDRAENDRA Life SciencesN/AN/AN/AN/A$0.67 per shareN/APEYEPrecision Optics$15.68M0.00N/AN/A$0.53 per share0.00Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHFSNuwellis-$18.11M-$279.28N/AN/AN/A-254.26%-173.61%-131.01%N/AEYESSecond Sight Medical Products-$8.92MN/A0.00N/AN/AN/A-13.58%-13.02%N/ANDRAENDRA Life Sciences-$10.06M-$1.26N/A∞N/AN/A-204.78%-153.48%8/12/2024 (Estimated)PEYEPrecision Optics-$930K-$0.06N/AN/AN/A-5.93%-12.10%-6.41%N/ALatest EYES, NDRA, CHFS, and PEYE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2024Q1 2024NDRAENDRA Life SciencesN/A-$0.26-$0.26-$0.26N/AN/A3/28/2024Q4 2023NDRAENDRA Life SciencesN/A-$0.17-$0.17-$0.17N/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCHFSNuwellisN/AN/AN/AN/AN/AEYESSecond Sight Medical ProductsN/AN/AN/AN/AN/ANDRAENDRA Life SciencesN/AN/AN/AN/AN/APEYEPrecision OpticsN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHFSNuwellisN/A6.875.97EYESSecond Sight Medical ProductsN/A22.1522.15NDRAENDRA Life SciencesN/A1.041.04PEYEPrecision Optics0.231.420.76OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHFSNuwellis65.06%EYESSecond Sight Medical ProductsN/ANDRAENDRA Life Sciences1.19%PEYEPrecision OpticsN/AInsider OwnershipCompanyInsider OwnershipCHFSNuwellis0.60%EYESSecond Sight Medical Products47.20%NDRAENDRA Life Sciences4.80%PEYEPrecision Optics22.70%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCHFSNuwellis666.04 millionN/ANot OptionableEYESSecond Sight Medical Products1513.14 million6.94 millionOptionableNDRAENDRA Life Sciences2111.04 million10.51 millionNot OptionablePEYEPrecision Optics5016.92 million13.08 millionNot OptionableEYES, NDRA, CHFS, and PEYE HeadlinesRecent News About These CompaniesMay 21, 2024 | msn.comPrecision and Power: The Top Handguns for Military Tech and Tactical EnthusiastsMay 13, 2024 | msn.comCutting-Edge Optics: US Special Forces Seek Augmented Reality AdvancementsMay 4, 2024 | msn.comNew quantum sensing scheme could lead to enhanced high-precision nanoscopic techniquesApril 30, 2024 | sgbonline.comGerman Precision Optics Hires Northeast Sales GroupApril 26, 2024 | wkbkradio.comKSC receives federal funding to bolster precision manufacturingApril 24, 2024 | optics.orgCountdown to Optatec; 400 exhibitors to explore optical manufacturingApril 11, 2024 | optics.orgPrivate equity group agrees $19M acquisition of Inrad OpticsApril 9, 2024 | rbj.netRochester optics firm names new leaderMarch 28, 2024 | msn.comGUNNAR Optiks Spring SaleMarch 18, 2024 | bbc.comIléeṣẹ́ ọlọ́pàá ṣèlérí ààbò tó péye fáwọn tó fẹ́ kópa nínú ìfẹ̀hónúhàn ṣùgbọ́n...February 20, 2024 | opprairie.comInnovations Shaping The Future Of High Precision Asphere Lenses Market DynamicsFebruary 17, 2024 | morningstar.comPrecision Optics Corp Inc POCIFebruary 15, 2024 | finance.yahoo.comQ2 2024 Precision Optics Corporation Inc Earnings CallFebruary 15, 2024 | insidermonkey.comPrecision Optics Corporation, Inc. (NASDAQ:POCI) Q2 2024 Earnings Call TranscriptFebruary 14, 2024 | finance.yahoo.comPrecision Optics Reports Second Quarter Fiscal Year 2024 Financial ResultsFebruary 8, 2024 | msn.comNew spiral-shaped lens could revolutionize eyewear technologyFebruary 2, 2024 | msn.comHow the Optic ID biometric system unlocks Apple Vision ProJanuary 29, 2024 | yahoo.comNew marine binoculars from Steiner auto-adjust brightness for all conditionsDecember 6, 2023 | finance.yahoo.comEurope Precision Optics Market Analysis and Forecast to 2031 - Growing Demand for Lenses, Mirrors, Windows and FiltersNovember 16, 2023 | finanznachrichten.dePrecision Optics Corporation: Precision Optics Reports First Quarter Fiscal Year 2024 Financial ResultsNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesIntel's Secret Plan for a Double-Digit Stock Rally RevealedBy Gabriel Osorio-Mazilli | June 7, 2024View Intel's Secret Plan for a Double-Digit Stock Rally RevealedStock market today: Wall Street hangs around its records after European stocks slumpBy The Associated Press | June 14, 2024View Stock market today: Wall Street hangs around its records after European stocks slumpTop 3 Stocks Set to Soar with the AI-Driven Metaverse RevolutionBy Thomas Hughes | June 10, 2024View Top 3 Stocks Set to Soar with the AI-Driven Metaverse RevolutionTop 4 Fastest Growing S&P 500 Dividends: Buy, Sell, or Hold?By Thomas Hughes | June 12, 2024View Top 4 Fastest Growing S&P 500 Dividends: Buy, Sell, or Hold?Chevron Eyes Hess, Exxon Resists: Here's the TradeBy Gabriel Osorio-Mazilli | May 31, 2024View Chevron Eyes Hess, Exxon Resists: Here's the TradeCompany DescriptionsNuwellisNASDAQ:CHFSNuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.Second Sight Medical ProductsNASDAQ:EYESSecond Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.ENDRA Life SciencesNASDAQ:NDRAENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.Precision OpticsOTCMKTS:PEYEPrecision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.